Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 50 μg/ 75 μg Tablets

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions

Pharmacokinetics

Interventions

DRUG

levothyroxine

DRUG

levothyroxine

Trial Locations (1)

Clinical Research Unit, University of Heidelberg, Heidelberg